Emerging safety issues in alemtuzumab-treated MS patients

Research output: Contribution to journal › Editorial › Academic › peer-review

14 Citations (Scopus)

Access to Document

@article{27ea8082d22f4512a7ecc9b511288ba5,

title = "Emerging safety issues in alemtuzumab-treated MS patients",

author = "Joep Killestein and {van Oosten}, Bob",

year = "2019",

month = aug,

day = "1",

doi = "https://doi.org/10.1177/1352458519851219",

language = "English",

volume = "25",

pages = "1206--1208",

journal = "MULTIPLE SCLEROSIS JOURNAL",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "9",

}

TY - JOUR

T1 - Emerging safety issues in alemtuzumab-treated MS patients

AU - Killestein, Joep

AU - van Oosten, Bob

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85070893418&partnerID=8YFLogxK

U2 - https://doi.org/10.1177/1352458519851219

DO - https://doi.org/10.1177/1352458519851219

M3 - Editorial

C2 - 31368417

SN - 1352-4585

VL - 25

SP - 1206

EP - 1208

JO - MULTIPLE SCLEROSIS JOURNAL

JF - MULTIPLE SCLEROSIS JOURNAL

IS - 9

ER -